7
Views
103
CrossRef citations to date
0
Altmetric
Cell Growth and Development

E2F and Histone Deacetylase Mediate Transforming Growth Factor β Repression of cdc25A during Keratinocyte Cell Cycle Arrest

&
Pages 916-922 | Received 26 Jun 1998, Accepted 02 Oct 1998, Published online: 28 Mar 2023
 

Abstract

cdc25A is a tyrosine phosphatase that activates G1cyclin-dependent kinases (Cdk’s). In human keratinocytes,cdc25A expression is down-regulated after the initial drop in Cdk activity caused by cell exposure to the antimitogenic cytokine transforming growth factor β (TGF-β) or removal of serum factors. Here we show that the TGF-β-inhibitory-response element in the cdc25A promoter maps to an E2F site at nucleotides −62 to −55 from the transcription start site. This site is not required for basal transcription in keratinocytes. We provide evidence that the cell cycle arrest program activated by TGF-β in human keratinocytes includes the generation of E2F4-p130 complexes that in association with histone deacetylase HDAC1 inhibit the activity of the cdc25A promoter from this repressor E2F site. This mechanism is part of a program that places keratinocytes in the quiescent state following the initial drop in Cdk activity caused by cell exposure to TGF-β.

ACKNOWLEDGMENTS

We thank Charles Zhang for expert technical assistance and Stacy Blain for critically reading the manuscript.

A.I. was the recipient of a fellowship from the Clinical Scholars Training Program of the Memorial Sloan-Kettering Cancer Center. J.M. is an Investigator of the Howard Hughes Medical Institute.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.